Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
About this item
Full title
Author / Creator
Reif, Andreas , Bitter, Istvan , Buyze, Jozefien , Cebulla, Kerstin , Frey, Richard , Fu, Dong-Jing , Ito, Tetsuro , Kambarov, Yerkebulan , Llorca, Pierre-Michel , Oliveira-Maia, Albino J. , Messer, Thomas , Mulhern-Haughey, Siobhán , Rive, Benoît , von Holt, Christian , Young, Allan H. , Godinov, Yordan and ESCAPE-TRD Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this randomized trial, esketamine nasal spray plus an SSRI or SNRI was superior to quetiapine plus an SSRI or SNRI with respect to remission at week 8 in patients with treatment-resistant depression.
Alternative Titles
Full title
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
Authors, Artists and Contributors
Author / Creator
Bitter, Istvan
Buyze, Jozefien
Cebulla, Kerstin
Frey, Richard
Fu, Dong-Jing
Ito, Tetsuro
Kambarov, Yerkebulan
Llorca, Pierre-Michel
Oliveira-Maia, Albino J.
Messer, Thomas
Mulhern-Haughey, Siobhán
Rive, Benoît
von Holt, Christian
Young, Allan H.
Godinov, Yordan
ESCAPE-TRD Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2873253822
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2873253822
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2304145
